- This topic has 3 replies, 2 voices, and was last updated 8 years, 1 month ago by
.
-
For our New Zealand members and guests, please see the link below to the New Zealand Society of Gastroenterology latest guidelines for treatment of HCV. While sadly only genotype 1 is currently funded for DAAs by Pharmac it is good to see the direct link to FixHepC as a reliable source of DAAs for those who do not wish or are unable to use Peg-IFN in the section on treatment for genotypes 2,3,4,5 & 6 at the bottom of page one.
http://www.nzsg.org.nz/cms2/uploads/Hepatitis%20C%20Guidance_FINAL%20July%2011.pdf
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
The New Zealand Hepatitis Foundation also has a live link.
If you do decide to personally import treatments, we recommend you:
only consider overseas suppliers who demonstrate they have a thorough process to test the authenticity of the drugs, such as The Fix Hep C Buyers Club.
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
In more good news for New Zealand patients the latest Spring 2016 NZHF “Talking Hep C” magazine is out now and includes a significant article by leading Hepatologist and researcher Professor Ed Gane that provides important information for New Zealanders with HCV.
Starting on page 6 he writes about the roll out of community (GP) based prescribing of Viekera Pak for genotype 1 patients and how to access it.
He then goes on to discuss personal importation of generic medications by genotype 2-6 patients who can’t or won’t wait for Pharmac funding of DAAs including step by step instructions on how to access the FixHepC Redemption e-Trials starting on page 8.It is reassuring to see such an influential doctor supporting their patient’s best interests.
G3a since ’78 – Dx ’12 – F4 (2xHCC)
24wk Tx – PEG/Riba/Dac 2013 relapsed
24wk Tx – Generic Sof/Dac/Riba 2015/16 relapsed
16wk Tx – 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof
SVR7 – 22/06/17 UND
SRV12 – 27/07/17 UND
SVR24 – 26/10/17 UND
- You must be logged in to reply to this topic.